Abstracts Journal of Thoracic Oncology

Slides:

Advertisements

Similar presentations

Belani CP et al. ASCO 2009; Abstract CRA8000. (Oral Presentation)

Advertisements

Frances A Shepherd, MD, Rafael Rosell, MD Journal of Thoracic Oncology

Lung squamous cell carcinoma

Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Epidermal Growth Factor Receptor-Related Tumor Markers and Clinical Outcomes with Erlotinib in Non-small Cell Lung Cancer: An Analysis of Patients from.

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Cost-Effectiveness of Pemetrexed Plus Cisplatin as First-Line Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer Robert Klein, MS, Catherine.

Zachary S. Morris, MD, PhD, Donald M. Cannon, MD, Brett A

SC17.02 Lung Cancer in China: Challenges and Perspectives

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.

Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer Howard West, MD, Rogerio Lilenbaum, MD, David Harpole,

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

EGFR Molecular Profiling in Advanced NSCLC: A Prospective Phase II Study in Molecularly/Clinically Selected Patients Pretreated with Chemotherapy Michele.

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.

Association of Epidermal Growth Factor Receptor Activating Mutations with Low ERCC1 Gene Expression in Non-small Cell Lung Cancer David R. Gandara, MD,

MET-Mutated NSCLC with Major Response to Crizotinib

The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non–Small-Cell.

First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status Young Joo Lee, MD, Heung Tae Kim, MD,

NA Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Should Patients with Extrapulmonary Small-Cell Carcinoma Receive Prophylactic Cranial Irradiation? Jarushka Naidoo, MB BcH BAO, MRCPI, Min Yuen Teo,

ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated.

The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials Krista.

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung Katsunari Matsuoka, MD, Shinichi Sumitomo, MD,

Meta-Analysis of First-Line Therapies in Advanced Non–Small-Cell Lung Cancer Harboring EGFR-Activating Mutations Benjamin Haaland, PhD, Pui San Tan,

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases Tao.

Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green

The Prognostic Impact of KRAS, Its Codon and Amino Acid Specific Mutations, on Survival in Resected Stage I Lung Adenocarcinoma Benjamin Izar, MD, PhD,

Pharmacokinetics of Gefitinib Predicts Antitumor Activity for Advanced Non-small Cell Lung Cancer Yoichi Nakamura, MD, PhD, Kazumi Sano, PhD, Hiroshi.

Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.

High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer Heounjeong Go, MD, Yoon Kyung Jeon, MD, PhD, Hyo Jin.

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy.

Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Liru He, MD, Pamela K. Allen, PhD, Adam.

EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer Philip C. Mack,

Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated.

Mitotic Inhibitors Journal of Thoracic Oncology

Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non- small Cell Lung Cancer Eric Duncavage, MD, Boone Goodgame, MD, Ananth Sezhiyan,

P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma Gustavo A. Lyons, Silvia Quadrelli,

The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer Ryo Maeda, MD, Junji Yoshida, MD, PhD, Genichiro Ishii, MD, PhD,

Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.

A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel.

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell.

Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,

KRAS Mutations in Advanced Nonsquamous Non–Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Based Chemotherapy Have No Predictive Value

A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell.

Ernest Nadal, MD, Guoan Chen, MD, PhD, John R

International Thymic Malignancies Interest Group: A Way Forward

Efficacy of BSI-201, a PARP Inhibitor, in Combination with Gemcitabine/Carboplatin (GC) in Triple Negative Metastatic Breast Cancer (mTNBC): Results.

Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer Eun Young Kim, MD, Young Saing Kim, MD, Inkeun Park, MD,

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

IASLC 6th Latin American Conference on Lung Cancer

Christina S. Baik, MD, MPH, Marc C. Chamberlain, MD, Laura Q. Chow, MD

Figure S1. A. B. Figure S1. Kaplan-Meier curve of progression-free survival by treatment group in soluble heregulin (HRG)-high population (A) and soluble.

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Efficacy of nivolumab in Japanese patients with advanced non-squamous non-small cell lung cancer (A) Kaplan-Meier curve for PFS, (B) Kaplan-Meier curve.

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell.

Kaplan–Meier analysis of PFS and OS in patients with advanced non-small cell lung cancer with adenocarcinoma histology with time since start of first-line.

Time Trends of Surgical Outcome in Patients with Non-small Cell Lung Cancer Takeshi Hanagiri, MD, PhD, Tetsuro Baba, MD, PhD, Tetsuya So, MD, PhD, Manabu.

Presentation transcript:

Abstracts Journal of Thoracic Oncology Journal of Thoracic Oncology Volume 4, Issue 9, Pages S5-S968 (September 2009) DOI: 10.1097/JTO.0b013e3181b9c77e Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure Empiric Approach to Selection of Therapy for NSCLC Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Map 1 Parties to the WHO FCTC in the South America sub-region6 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Map 2 Taxes in the South America sub-region Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Map 3 Packaging and labeling regulations in the South America sub-region Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Map 4 Smoke-free environments in the South America sub-region Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Map 5 Advertising, promotion and sponsorship bans in the South America sub-region Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Bronchial confocal microendoscopy imaging: A. Normal elastic fibered network of the basement membrane zone. B. Disorganized basement membrane zone elastic network at the vicinity of a bronchial CIS C. Regular normal bronchial epithelium 660 nm excitation FCFM after topical application of methylene blue (0,1%). D. CIS imaging, FCFM at 660 nm and topical methylene blue. Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 FCFM imaging of normal distal lung and peripheral lung nodule: A. FCFM imaging of normal distal lung B. Interstitial fiber network disorganisation in a peripheral lung adenocarcinoma (488 nm excitation wave length) C. FCFM cellular imaging of a peripheral lung adenocarcinoma (660 nm excitation and topical methylene blue) Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1A Median survival of patients with ERCC1 of > 50 (94.6 months) vs < 50 (35.5 months) (p = 0.01). Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1B Median survival of patients with ERCC1 of < 30 (35.5 months), 30 to 100 (62.1 months), and > 100 (94.6 months) (p = 0.03, two-sided log-rank test). (Adapted from Simon et al with permission (3)). Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2(A) Overall survival (OS) and progression-free survival (PFS) of 53 patients with advanced non-small-cell lung cancer treated with chemotherapy based on expression of the genes ribonucleotide reductase subunit 1 (RRM1) and excision repair cross-complementing group 1 gene (ERCC1). Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2(B) Overall survival (OS) by assigned chemotherapy. DC, docetaxel and carboplatin; GC, gemcitabine and carboplatin; DV, docetaxel and vinorelbine; GD, gemcitabine and docetaxel. Adapted with permission from Simon et al(15). Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Examples of dose-efficacy curves for targeted agents and novel therapies Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Cancer stem cell–specific therapeutic approaches. Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1a Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1b Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Image 1 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Image 2 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Image 3 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Image 4 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Image 1 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Overall survival based on EGFR and KRAS status. Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Comparison of outcomes by clinical enrichment and EGFR mutation analysis. Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Boxplots of the expression levels ofTS In NSCLC-SCCA. NSCLC-adenoca and CRC are demonstrated. Statistical differences in TS expression levels are displayed in the figure (Mann-Whitney Test). Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Boxplots of the expression levels of RRM1 in NSCLC-SCCA and NSCLC-adenoca are demonstrated The statistical significance of íhe RRM1 expression levels of the &vo histological NSCLC types is displayed in trie figure (Mann-Whitney Test pO.001). Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Image 1 Comparison of ABS on axial, coronal, sagittal and tilted planes of HRCT Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Area of Consolidation & Proportion of Consolidation Scattered Plots Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Disease Free Survival (DFS) and Overall Survival (OS). Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Increased expression of TRAIL by SAHA Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 C4.4A expression in bronchial squamous metaplasia Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Type 1, widespread leptomeninges metastases (3 of 7) Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Type 2, multiple diffuse small nodules (6 of 7) Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Patient with squamous cell carcinoma of the lung: Axial, coronal and sagittal 18F-HX4 PET images 120 minutes after injection. Tumour to muscle ratio: 1.77 Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Example of Histogram analysis Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 SM correlated with the clinical response of MM pts: a decreasing trend in pts with partial response (left) and an increasing trend in pts with progressive disease (right) was present. c1-6: chemo cycle 1-6. Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Overall survival Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Progression free survival Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 TNM staging for Sarcomas according to grade and size of tumors Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10. 1097/JTO Journal of Thoracic Oncology 2009 4, S5-S968DOI: (10.1097/JTO.0b013e3181b9c77e) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions